Clinical Trials in Massachusetts

Showing 7521-7540 of 17,868 trials

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

NCT02214160

The primary objective of this study is to evaluate the long-term safety and efficacy of UX007 in participants with LC-FAOD. The secondary objectives of this study are to evaluate the effect of UX007 on energy metabolism in LC-FAOD and evaluate the impact of UX007 on clinical events associated with LC-FAOD.

Carnitine Palmitoyltransferase (CPT I or CPT II) DeficiencyVery Long Chain Acyl-CoA Dehydrogenase (VLCAD) DeficiencyLong-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency+2 more

Ultragenyx Pharmaceutical Inc94 participantsStarted Dec 2014

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Tampa, Florida, United States +8 more locations

COMPLETEDNA26 miles

A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions

NCT04382521

This is a randomized pilot trial to examine the feasibility, acceptability, and preliminary efficacy of an adaptive text message intervention (TMI) to promote well-being and health behavior adherence in 60 patients with two or more cardiac risk conditions (hypertension, type 2 diabetes, or hyperlipidemia).

HyperlipemiaHypertensionType2 Diabetes

Massachusetts General Hospital69 participantsStarted Sep 2020

Boston, Massachusetts, United States

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions

Find Trials by Condition in Massachusetts

Replication of the EINSTEIN-PE Anticoagulant Trial in Healthcare Claims Data

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects

Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing

Replication of the DECLARE Diabetes Trial in Healthcare Claims

Replication of the TECOS Diabetes Trial in Healthcare Claims

Replication of the CANVAS Diabetes Trial in Healthcare Claims

Digital Fall Prevention Study

Replication of the RELY Anticoagulant Trial in Healthcare Claims Data

Optical Frequency Domain Imaging for Assessing Colonic Polyps

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Reducing Veterans Hospitalizations From Community Living Centers

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb

A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study